People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AcuFocus, Inc. | — | Biotechnology | Series C | $167.7M | $981.9M | 2016 |
| Eyconis, Inc. | — | Other | Series C | $85.3M | $150.3M | 2024 |
| CranioVation, Inc. | — | Other Health Care | Series B | $56.7M | $174.9M | 2025 |
Conrad Wang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Conrad Wang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Thompson | 1 | 16 |
| William J. Link | 1 | 10 |
| Buzz Benson | 1 | 8 |
| Charles Larsen | 1 | 7 |
| Aaron Sandoski | 1 | 7 |
| James Garvey | 1 | 6 |
| Klaus Veitinger | 1 | 6 |
| Robert Stein | 1 | 6 |
| Robert E. Grant | 1 | 5 |
| Juan-Pablo Mas | 1 | 5 |
| Emmett Cunningham | 1 | 4 |
| Ali J. Satvat | 1 | 4 |
| Charles M. Warden | 1 | 3 |
| Daniel Estes | 1 | 3 |
| Ryan M. Schwarz | 1 | 3 |
| Anna Chen | 1 | 3 |
| GREG MADDEN | 1 | 3 |
| Dan Estes | 1 | 3 |
| James V. Mazzo | 1 | 2 |
| Charles V. Larsen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.